Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
AstraZeneca
McKesson
Harvard Business School

Last Updated: May 27, 2022

Investigational Drug Information for Resminostat


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Resminostat?

Resminostat is an investigational drug.

There have been 6 clinical trials for Resminostat. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Carcinoma, Mycoses, and Lymphoma, T-Cell, Cutaneous. The leading clinical trial sponsors are 4SC AG, Yakult Honsha Co., LTD, and [disabled in preview].

Recent Clinical Trials for Resminostat
TitleSponsorPhase
A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat4SC AGPhase 1
Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or S├ęzary Syndrome (SS)4SC AGPhase 2
Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)Yakult Honsha Co., LTDPhase 1/Phase 2

See all Resminostat clinical trials

Clinical Trial Summary for Resminostat

Top disease conditions for Resminostat
Top clinical trial sponsors for Resminostat

See all Resminostat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
AstraZeneca
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.